Inclusion criteria | |
Patients presenting a first-ever ischemic or intracerebral hemorrhagic stroke | |
A CT scan and/or MRI to exclude other pathologies | |
Lesion localization by clinical symptoms/signs | |
Moderate to mild proximal upper limb motor impairment (MRC ≥ 2) and/or moderate to severe non-fluent aphasia (Barcelona test or equivalent) | |
Age 20–85 years old | |
Able to sit on a chair or a wheelchair interacting with RGS during a full session and be capable and willing to participate in RGS therapy | |
Exclusion criteria | |
Presence of a condition or abnormality that, in the opinion of the investigator, would compromise the safety of the patient or the quality of the data | |
Severe cognitive capabilities preventing the execution of the experiment (MoCA < 19), but the final decision is under the clinician’s criterion | |
Arteriovenous malformation or lesions not related to a stroke | |
Severe associated impairment such as proximal but not distal spasticity, communication disabilities (sensory, Wernicke aphasia, or apraxia), major pain or other neuromuscular impairments, or orthopedic devices that would interfere with the correct execution of the experiment (Modified Ashworth Scale < 3) | |
Unable to use RGS independently according to the clinician’s observations and lacking support from a caregiver to use RGS | |
Refusal to sign the informed consent form | |
Pre-stroke history of upper limb motor disability |